首页 > 最新文献

Advances in medical sciences最新文献

英文 中文
Circadian and Autophagy Markers Correlate with Poor Prognosis in Meningioma Patients. 昼夜节律和自噬标记与脑膜瘤患者预后不良有关
IF 2.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-22 DOI: 10.1016/j.advms.2025.01.006
Keng-Liang Kuo, Shu-Jyuan Chang, Cheng Yu Tsai, Yen-Shuo Huang, Aij-Lie Kwan, Chee-Yin Chai

Purpose: Patients with meningiomas mostly present good outcomes and optimal prognosis, but different grades of tumors have very different symptoms and recurrence rates. Therefore, effective diagnosis is crucial for early intervention and controlling tumor development. Circadian cycle and autophagy have both been proven to be related to neoplasm formation and pathogenesis; however, there is limited exploration and discussion on the relationships between the circadian cycle and autophagy in patients with meningiomas. This study was undertaken to elucidate the relationship between two autophagy markers (Beclin1, LC3B) and one circadian marker (NR1D1) with clinicopathological parameters in patients with meningiomas.

Materials and methods: Clinicopathological data of 124 enrolled patients were collected. Tissue-sectioned slides were analyzed via immunohistochemical stains and the relationship between the markers was evaluated.

Results: Individually low expression of NR1D1 and Beclin 1 was associated with better prognosis, lower pathological grade, and longer survival. Although correlation analysis showed that NR1D1, Beclin 1 and LC3B were related to each other. However, the dual marker NR1D1-/Beclin 1- was effective in predicting good prognosis in meningiomas, whereas NR1D1-/LC3B- was not.

Conclusion: NR1D1 and Beclin 1 could be adopted as a single marker or coupled as a combined marker to predict meningioma prognoses, pathological grades, and survival. This study provides insights into the association between autophagy and circadian cycles and may benefit future elucidation of molecular mechanisms.

{"title":"Circadian and Autophagy Markers Correlate with Poor Prognosis in Meningioma Patients.","authors":"Keng-Liang Kuo, Shu-Jyuan Chang, Cheng Yu Tsai, Yen-Shuo Huang, Aij-Lie Kwan, Chee-Yin Chai","doi":"10.1016/j.advms.2025.01.006","DOIUrl":"https://doi.org/10.1016/j.advms.2025.01.006","url":null,"abstract":"<p><strong>Purpose: </strong>Patients with meningiomas mostly present good outcomes and optimal prognosis, but different grades of tumors have very different symptoms and recurrence rates. Therefore, effective diagnosis is crucial for early intervention and controlling tumor development. Circadian cycle and autophagy have both been proven to be related to neoplasm formation and pathogenesis; however, there is limited exploration and discussion on the relationships between the circadian cycle and autophagy in patients with meningiomas. This study was undertaken to elucidate the relationship between two autophagy markers (Beclin1, LC3B) and one circadian marker (NR1D1) with clinicopathological parameters in patients with meningiomas.</p><p><strong>Materials and methods: </strong>Clinicopathological data of 124 enrolled patients were collected. Tissue-sectioned slides were analyzed via immunohistochemical stains and the relationship between the markers was evaluated.</p><p><strong>Results: </strong>Individually low expression of NR1D1 and Beclin 1 was associated with better prognosis, lower pathological grade, and longer survival. Although correlation analysis showed that NR1D1, Beclin 1 and LC3B were related to each other. However, the dual marker NR1D1-/Beclin 1- was effective in predicting good prognosis in meningiomas, whereas NR1D1-/LC3B- was not.</p><p><strong>Conclusion: </strong>NR1D1 and Beclin 1 could be adopted as a single marker or coupled as a combined marker to predict meningioma prognoses, pathological grades, and survival. This study provides insights into the association between autophagy and circadian cycles and may benefit future elucidation of molecular mechanisms.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143035836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and temporal-validation of prognostic models for 5-year risk of pneumonia, respiratory failure/collapse, and fracture among adults with cerebral palsy. 针对脑瘫成人肺炎、呼吸衰竭/塌陷和骨折 5 年风险的预后模型的开发和时间验证。
IF 2.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-22 DOI: 10.1016/j.advms.2025.01.007
Daniel G Whitney

Purpose: Pneumonia, respiratory failure, and fracture are common and highly burdensome for adults with cerebral palsy (CP). To date, there are no clinically friendly tools to assess individualized risk of these outcomes for adults with CP. The objective was to develop and validate prognostic models for 5-year risk of pneumonia, respiratory failure/collapse, and fracture for adults with CP.

Patients and methods: This single medical center retrospective cohort study used medical records from January 1, 2012 till June 1, 2024 from adults ≥18 years old with CP. The development cohort (n=1,520) included those with a start date of follow-up from January 1, 2015 till December 31, 2015 and evidence of being treated at the medical center for ≥3 years prior to day 0. The 5-year risk of outcomes was modelled using logistic regression and variations of the following predictors that were collected during the 3-year baseline: age, sex, Whitney Comorbidity Index, pneumonia, respiratory failure/collapse, fracture, and asthma/COPD. Discrimination (c-statistic) and calibration statistics assessed the model's performance. Decision curve analysis assessed the model's clinical utility. The models were validated in a temporal validation cohort, whose start date of follow-up was January 1, 2016 to May 31, 2019 (n=529).

Results: The prognostic models had good discrimination (c-statistic=0.76-0.78), good-to-excellent calibration, and demonstrated superior clinical utility in identifying true positives and true negatives. All models demonstrated temporal validation.

Conclusions: Prognostic models for 5-year risk of outcomes were developed and temporally validated for adults with CP using measures that can be easily collected from medical records.

{"title":"Development and temporal-validation of prognostic models for 5-year risk of pneumonia, respiratory failure/collapse, and fracture among adults with cerebral palsy.","authors":"Daniel G Whitney","doi":"10.1016/j.advms.2025.01.007","DOIUrl":"https://doi.org/10.1016/j.advms.2025.01.007","url":null,"abstract":"<p><strong>Purpose: </strong>Pneumonia, respiratory failure, and fracture are common and highly burdensome for adults with cerebral palsy (CP). To date, there are no clinically friendly tools to assess individualized risk of these outcomes for adults with CP. The objective was to develop and validate prognostic models for 5-year risk of pneumonia, respiratory failure/collapse, and fracture for adults with CP.</p><p><strong>Patients and methods: </strong>This single medical center retrospective cohort study used medical records from January 1, 2012 till June 1, 2024 from adults ≥18 years old with CP. The development cohort (n=1,520) included those with a start date of follow-up from January 1, 2015 till December 31, 2015 and evidence of being treated at the medical center for ≥3 years prior to day 0. The 5-year risk of outcomes was modelled using logistic regression and variations of the following predictors that were collected during the 3-year baseline: age, sex, Whitney Comorbidity Index, pneumonia, respiratory failure/collapse, fracture, and asthma/COPD. Discrimination (c-statistic) and calibration statistics assessed the model's performance. Decision curve analysis assessed the model's clinical utility. The models were validated in a temporal validation cohort, whose start date of follow-up was January 1, 2016 to May 31, 2019 (n=529).</p><p><strong>Results: </strong>The prognostic models had good discrimination (c-statistic=0.76-0.78), good-to-excellent calibration, and demonstrated superior clinical utility in identifying true positives and true negatives. All models demonstrated temporal validation.</p><p><strong>Conclusions: </strong>Prognostic models for 5-year risk of outcomes were developed and temporally validated for adults with CP using measures that can be easily collected from medical records.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143035839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of therapeutic plasma exchange in pediatric neuro-immunological diseases. 血浆置换治疗小儿神经免疫疾病的安全性和有效性。
IF 2.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-15 DOI: 10.1016/j.advms.2025.01.003
Magdalena Błasiak, Przemysław Korohoda, Katarzyna Zachwieja, Dorota Drożdż, Aleksandra Gergont, Karina Madej-Świątkowska, Monika Miklaszewska

Purpose: Therapeutic plasma exchange (TPE) is the treatment of choice in various neuro-immunological disorders in pediatric populations. This study assesses the safety and efficacy of TPE in this demographic.

Materials and methods: A single-center, retrospective cohort study involving pediatric patients who experienced neuro-immunological events and underwent TPE procedures at a tertiary referral center was conducted.

Results: The study included 81 patients (Guillain-Barre: 65, polyneuropathies: 5, myasthenia gravis: 8, multiple sclerosis: 3), undergoing collectively 360 TPE procedures. Fresh frozen plasma (FFP) was used in 76.1% of the TPE procedures. Adverse events (AEs) occurred in 50% of TPEs using FFP compared to 39.5% without. For procedures with at least two AEs, the rates were 24.5% with FFP vs 8.1% without. Incidence of allergic AEs was significantly higher in the FFP group (94.2% of TPE with at least one AE) compared to those without FFP (47.2%). Serious AE accounted for 1.2% of TPE procedures and 2.5% of patients. Effectiveness evaluations using a scale developed for this study and the Hughes Functional Grading Scale showed no significant clinical pre-treatment differences. After completing the treatment, children in the polyneuropathies group had the most severe clinical condition, and the largest relative improvement in clinical status was in the myasthenia gravis group.

Conclusions: TPE conducted by filtration is an effective and safe therapy for pediatric neuro-immunological diseases, with benefits outweighing the risks of complications. The use of FFP in therapy increases the probability of AE by 27%, and significantly raises the risk of allergic and multiple AEs.

目的:治疗性血浆置换(TPE)是儿科人群中各种神经免疫疾病的治疗选择。本研究评估了TPE在这一人群中的安全性和有效性。材料和方法:一项单中心、回顾性队列研究,涉及在三级转诊中心经历神经免疫事件并接受TPE手术的儿科患者。结果:81例患者(吉兰-巴雷综合征65例,多发性神经病变5例,重症肌无力8例,多发性硬化症3例)共接受了360例TPE手术。76.1%的TPE手术采用新鲜冷冻血浆(FFP)。与未使用FFP的39.5%相比,使用FFP的tpe中有50%发生不良事件(ae)。对于至少有两次ae的手术,有FFP的发生率为24.5%,而没有FFP的发生率为8.1%。FFP组过敏性不良事件的发生率(94.2%)明显高于无FFP组(47.2%)。严重AE占TPE手术的1.2%,占患者的2.5%。使用为本研究开发的量表和Hughes功能分级量表进行的有效性评估显示,临床治疗前无显著差异。治疗结束后,多神经病变组患儿临床状况最严重,重症肌无力组患儿临床状况相对改善最大。结论:滤过式TPE治疗小儿神经免疫疾病是一种安全有效的治疗方法,其益处大于并发症的风险。使用FFP治疗可使AE的发生概率增加27%,并显著增加过敏和多发AE的发生风险。
{"title":"Safety and efficacy of therapeutic plasma exchange in pediatric neuro-immunological diseases.","authors":"Magdalena Błasiak, Przemysław Korohoda, Katarzyna Zachwieja, Dorota Drożdż, Aleksandra Gergont, Karina Madej-Świątkowska, Monika Miklaszewska","doi":"10.1016/j.advms.2025.01.003","DOIUrl":"https://doi.org/10.1016/j.advms.2025.01.003","url":null,"abstract":"<p><strong>Purpose: </strong>Therapeutic plasma exchange (TPE) is the treatment of choice in various neuro-immunological disorders in pediatric populations. This study assesses the safety and efficacy of TPE in this demographic.</p><p><strong>Materials and methods: </strong>A single-center, retrospective cohort study involving pediatric patients who experienced neuro-immunological events and underwent TPE procedures at a tertiary referral center was conducted.</p><p><strong>Results: </strong>The study included 81 patients (Guillain-Barre: 65, polyneuropathies: 5, myasthenia gravis: 8, multiple sclerosis: 3), undergoing collectively 360 TPE procedures. Fresh frozen plasma (FFP) was used in 76.1% of the TPE procedures. Adverse events (AEs) occurred in 50% of TPEs using FFP compared to 39.5% without. For procedures with at least two AEs, the rates were 24.5% with FFP vs 8.1% without. Incidence of allergic AEs was significantly higher in the FFP group (94.2% of TPE with at least one AE) compared to those without FFP (47.2%). Serious AE accounted for 1.2% of TPE procedures and 2.5% of patients. Effectiveness evaluations using a scale developed for this study and the Hughes Functional Grading Scale showed no significant clinical pre-treatment differences. After completing the treatment, children in the polyneuropathies group had the most severe clinical condition, and the largest relative improvement in clinical status was in the myasthenia gravis group.</p><p><strong>Conclusions: </strong>TPE conducted by filtration is an effective and safe therapy for pediatric neuro-immunological diseases, with benefits outweighing the risks of complications. The use of FFP in therapy increases the probability of AE by 27%, and significantly raises the risk of allergic and multiple AEs.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of circulating natural autoantibodies against ANXA1 and MYC as potential biomarkers in hepatocellular carcinoma. 抗ANXA1和MYC的循环天然自身抗体作为肝细胞癌潜在生物标志物的研究。
IF 2.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-15 DOI: 10.1016/j.advms.2025.01.004
Jiaxin Wang, Siqi Liu, Xuan Zhang

Purpose: In this study, we examined novel autoantibodies targeting tumor-associated antigens (TAAs) as biomarkers for clinical assessment of hepatocellular carcinoma (HCC) in a Chinese population.

Methods and methods: A total of 119 patients with HCC and 130 healthy control (HC) volunteers who were age and gender matched were enrolled. The levels of circulating IgG antibodies were detected using an enzyme-linked immunosorbent test (ELISA) developed in-house with linear peptide antigens derived from Annexin A1(ANXA1) and proto-oncogene protein (MYC). The significant level was set at P<0.025 as two tests were performed.

Results: In comparison to the HC group, plasma level of ANXA1 autoantibodies was significantly elevated in HCC patients (t=-3.174, P = 0.002) but the change of plasma MYC autoantibody levels failed to reach the significance level (P>0.025). There was a significant increase in these two plasma IgG autoantibodies in male HCC patients (ANXA1: t=-3.590, P<0.001; MYC: t=-2.706, P=0.007). Pearson correlation analysis demonstrated that both anti-ANXA1 and anti-MYC IgG levels had a positive correlation with BCLC staging (both P <0.025) but a negative correlation with plasma albumin (Alb) (both P <0.025). The area under the ROC curve (AUC) values were 0.613 for anti-ANXA1 IgG assay and 0.567 for anti-MYC IgG assay. The anti-ANAXA1 IgG assay showed a high sensitivity of 31.4% against the specificity of 90.0% for detection of BCLC stages C+D.

Conclusions: Plasma anti-ANXA1 and anti-MYC autoantibodies are likely to serve as a potential biomarker for clinical assessment of HCC prognosis, particularly in male patients.

目的:在这项研究中,我们检测了靶向肿瘤相关抗原(TAAs)的新型自身抗体作为中国人群肝细胞癌(HCC)临床评估的生物标志物。方法和方法:共纳入119例HCC患者和130例年龄和性别匹配的健康对照(HC)志愿者。采用酶联免疫吸附试验(ELISA)检测循环IgG抗体水平,该试验采用源自膜联蛋白A1(ANXA1)和原癌基因蛋白(MYC)的线性肽抗原。结果:HCC患者血浆中ANXA1自身抗体水平较HC组显著升高(t=-3.174, P = 0.002),而MYC自身抗体水平变化未达到显著水平(P = 0.025)。在男性HCC患者中,这两种血浆IgG自身抗体显著升高(ANXA1: t=-3.590, p)。结论:血浆抗ANXA1和抗myc自身抗体可能作为HCC临床预后评估的潜在生物标志物,尤其是在男性患者中。
{"title":"Investigation of circulating natural autoantibodies against ANXA1 and MYC as potential biomarkers in hepatocellular carcinoma.","authors":"Jiaxin Wang, Siqi Liu, Xuan Zhang","doi":"10.1016/j.advms.2025.01.004","DOIUrl":"https://doi.org/10.1016/j.advms.2025.01.004","url":null,"abstract":"<p><strong>Purpose: </strong>In this study, we examined novel autoantibodies targeting tumor-associated antigens (TAAs) as biomarkers for clinical assessment of hepatocellular carcinoma (HCC) in a Chinese population.</p><p><strong>Methods and methods: </strong>A total of 119 patients with HCC and 130 healthy control (HC) volunteers who were age and gender matched were enrolled. The levels of circulating IgG antibodies were detected using an enzyme-linked immunosorbent test (ELISA) developed in-house with linear peptide antigens derived from Annexin A1(ANXA1) and proto-oncogene protein (MYC). The significant level was set at P<0.025 as two tests were performed.</p><p><strong>Results: </strong>In comparison to the HC group, plasma level of ANXA1 autoantibodies was significantly elevated in HCC patients (t=-3.174, P = 0.002) but the change of plasma MYC autoantibody levels failed to reach the significance level (P>0.025). There was a significant increase in these two plasma IgG autoantibodies in male HCC patients (ANXA1: t=-3.590, P<0.001; MYC: t=-2.706, P=0.007). Pearson correlation analysis demonstrated that both anti-ANXA1 and anti-MYC IgG levels had a positive correlation with BCLC staging (both P <0.025) but a negative correlation with plasma albumin (Alb) (both P <0.025). The area under the ROC curve (AUC) values were 0.613 for anti-ANXA1 IgG assay and 0.567 for anti-MYC IgG assay. The anti-ANAXA1 IgG assay showed a high sensitivity of 31.4% against the specificity of 90.0% for detection of BCLC stages C+D.</p><p><strong>Conclusions: </strong>Plasma anti-ANXA1 and anti-MYC autoantibodies are likely to serve as a potential biomarker for clinical assessment of HCC prognosis, particularly in male patients.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Downregulation and inhibition of TRPM2 calcium channel prevent oxidative stress-induced endothelial dysfunction in the EA.hy926 endothelial cells model - Preliminary studies. 下调和抑制TRPM2钙通道可预防EA.hy926内皮细胞模型中氧化应激诱导的内皮功能障碍——初步研究
IF 2.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-06 DOI: 10.1016/j.advms.2025.01.002
Wioletta Arendt, Klaudia Piekarska, Marta Hałas-Wiśniewska, Magdalena Izdebska, Alina Grzanka, Maciej Gagat

Purpose: Proper functioning of the endothelial barrier is crucial for cardiovascular system homeostasis. Oxidative stress can lead to endothelial dysfunction (ED), damaging lipids, proteins, and DNA. Reactive oxygen species also increase cytoplasmic Ca2+ levels, activating transient receptor potential melastatin 2 (TRPM2), a membrane non-selective calcium channel. The study aimed to assess TRPM2's significance in vascular endothelial cells' response to oxidative stress and the potential use of TRPM2 direct and indirect inhibitors in the prevention of oxidative stress-induced ED.

Materials and methods: EA.hy926 endothelial cells were exposed to hydrogen peroxide for 24 ​h to mimic oxidative stress conditions. To assess the significance of TRPM2 in the response of EA.hy926 ​cells to hydrogen peroxide TRPM2 siRNA as well as direct (N-(p-Amylcinnamoyl)anthranilic acid, flufenamic acid) and indirect (3-aminobenzamide, 3,4-dihydro-5[4-(1-piperidinyl)butyl]-1(2H)-isoquinolinone) TRPM2 inhibitors were tested.

Results: Results showed that hydrogen peroxide-induced ED is alleviated by TRPM2 downregulation. Moreover, preincubation of cells with both direct and indirect TRPM2 inhibitors for 30 ​min before hydrogen peroxide treatment reduces its negative effects on cell viability, cell migration, and junctional proteins.

Conclusions: The obtained results suggest that TRPM2 channel may be a potential target in therapy and prevention of cardiovascular diseases connected with oxidative stress-induced ED. However, further research is needed for clinical applications of direct and indirect TRPM2 inhibitors.

目的:内皮屏障的正常功能对心血管系统的稳态至关重要。氧化应激可导致内皮功能障碍(ED),损害脂质、蛋白质和DNA。活性氧也增加细胞质Ca2+水平,激活瞬时受体电位美拉抑素2 (TRPM2),这是一种膜非选择性钙通道。本研究旨在评估TRPM2在血管内皮细胞对氧化应激反应中的意义,以及TRPM2直接和间接抑制剂在预防氧化应激诱导ed中的潜在应用。材料和方法:将EA.hy926内皮细胞暴露在过氧化氢环境中24小时,模拟氧化应激条件。为了评估TRPM2在EA.hy926细胞对过氧化氢TRPM2 siRNA以及直接(N-(对氨基肉桂基)苯甲酸、氟芬那酸)和间接(3-氨基苯甲酰胺、3,4-二氢-5[4-(1-哌替啶基)丁基]-1(2H)-异喹啉酮)TRPM2抑制剂反应中的意义。结果:过氧化氢诱导的ED可通过下调TRPM2得到缓解。此外,在过氧化氢处理前,将细胞与直接和间接TRPM2抑制剂一起预孵养30分钟,可以减少其对细胞活力、细胞迁移和连接蛋白的负面影响。结论:上述结果提示TRPM2通道可能是治疗和预防氧化应激性ED相关心血管疾病的潜在靶点,但TRPM2直接和间接抑制剂的临床应用还需进一步研究。
{"title":"Downregulation and inhibition of TRPM2 calcium channel prevent oxidative stress-induced endothelial dysfunction in the EA.hy926 endothelial cells model - Preliminary studies.","authors":"Wioletta Arendt, Klaudia Piekarska, Marta Hałas-Wiśniewska, Magdalena Izdebska, Alina Grzanka, Maciej Gagat","doi":"10.1016/j.advms.2025.01.002","DOIUrl":"10.1016/j.advms.2025.01.002","url":null,"abstract":"<p><strong>Purpose: </strong>Proper functioning of the endothelial barrier is crucial for cardiovascular system homeostasis. Oxidative stress can lead to endothelial dysfunction (ED), damaging lipids, proteins, and DNA. Reactive oxygen species also increase cytoplasmic Ca<sup>2+</sup> levels, activating transient receptor potential melastatin 2 (TRPM2), a membrane non-selective calcium channel. The study aimed to assess TRPM2's significance in vascular endothelial cells' response to oxidative stress and the potential use of TRPM2 direct and indirect inhibitors in the prevention of oxidative stress-induced ED.</p><p><strong>Materials and methods: </strong>EA.hy926 endothelial cells were exposed to hydrogen peroxide for 24 ​h to mimic oxidative stress conditions. To assess the significance of TRPM2 in the response of EA.hy926 ​cells to hydrogen peroxide TRPM2 siRNA as well as direct (N-(p-Amylcinnamoyl)anthranilic acid, flufenamic acid) and indirect (3-aminobenzamide, 3,4-dihydro-5[4-(1-piperidinyl)butyl]-1(2H)-isoquinolinone) TRPM2 inhibitors were tested.</p><p><strong>Results: </strong>Results showed that hydrogen peroxide-induced ED is alleviated by TRPM2 downregulation. Moreover, preincubation of cells with both direct and indirect TRPM2 inhibitors for 30 ​min before hydrogen peroxide treatment reduces its negative effects on cell viability, cell migration, and junctional proteins.</p><p><strong>Conclusions: </strong>The obtained results suggest that TRPM2 channel may be a potential target in therapy and prevention of cardiovascular diseases connected with oxidative stress-induced ED. However, further research is needed for clinical applications of direct and indirect TRPM2 inhibitors.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":"62-78"},"PeriodicalIF":2.5,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142942466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical value of CEUS with tumour marker monitoring in evaluating the prognosis of HCC after MWA. 超声造影联合肿瘤标志物监测对肝癌MWA术后预后评价的临床价值。
IF 2.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-02 DOI: 10.1016/j.advms.2025.01.001
Qiang Guo, Yang Yu, Ruyun Ye, Zhiliang Huang, Tingting Shi

Purpose: This study aims to evaluate the prognostic value of contrast-enhanced ultrasound (CEUS) combined with tumour markers in patients with hepatocellular carcinoma (HCC) undergoing microwave ablation (MWA).

Methods: MWA patients with HCC were divided into good prognosis (n ​= ​75) and poor prognosis (n ​= ​69) groups. The levels of alpha-fetoprotein (AFP), carbohydrate antigen (CA19-9), and carcinoembryonic antigen (CEA) before and after MWA were analysed using an independent sample t-test. The correlation between prognosis, ablation lesion area, and tumour marker levels were analysed by Pearson's correlation. The diagnostic power of the ablation lesion area combined with tumour marker levels for the prognosis of patients with MWA was analysed using receiver operating characteristic (ROC) curves.

Results: The levels of AFP, CA19-9, and CEA in the good prognosis group were significantly lower than those in the poor prognosis group (all P ​< ​0.001). The levels of all tumour markers were significantly negatively correlated with the prognosis of patients who underwent MWA (all r ​< ​0, P ​< ​0.001) and positively correlated with the area of tumour-ablated lesions (r ​> ​0, P ​< ​0.001). Moreover, the diagnostic efficacy of CEUS combined with tumour markers for the prognosis of patients who underwent MWA was significantly higher than that of either single diagnostic modality.

Conclusions: CEUS combined with tumour marker monitoring can effectively improve the accuracy of prognostic diagnosis in patients with MWA and provide a reference for timely and reasonable treatment and therapeutic evaluation.

目的:本研究旨在评价超声造影(CEUS)联合肿瘤标志物在肝细胞癌(HCC)微波消融(MWA)患者中的预后价值。方法:将MWA合并HCC患者分为预后良好组(n = 75)和预后不良组(n = 69)。采用独立样本t检验分析MWA前后甲胎蛋白(AFP)、碳水化合物抗原(CA19-9)、癌胚抗原(CEA)水平。采用Pearson相关分析预后、消融病灶面积与肿瘤标志物水平的相关性。采用受试者工作特征(ROC)曲线分析消融病灶面积结合肿瘤标志物水平对MWA患者预后的诊断能力。结果:预后良好组患者AFP、CA19-9、CEA水平显著低于预后不良组(P均< 0.001)。所有肿瘤标志物水平与MWA患者预后呈显著负相关(均r < 0, P < 0.001),与肿瘤消融灶面积呈正相关(均r < 0, P < 0.001)。此外,超声造影联合肿瘤标志物对MWA患者预后的诊断效果显著高于任何一种单一诊断方式。结论:超声造影联合肿瘤标志物监测可有效提高MWA患者预后诊断的准确性,为及时合理的治疗和疗效评价提供参考。
{"title":"Clinical value of CEUS with tumour marker monitoring in evaluating the prognosis of HCC after MWA.","authors":"Qiang Guo, Yang Yu, Ruyun Ye, Zhiliang Huang, Tingting Shi","doi":"10.1016/j.advms.2025.01.001","DOIUrl":"10.1016/j.advms.2025.01.001","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to evaluate the prognostic value of contrast-enhanced ultrasound (CEUS) combined with tumour markers in patients with hepatocellular carcinoma (HCC) undergoing microwave ablation (MWA).</p><p><strong>Methods: </strong>MWA patients with HCC were divided into good prognosis (n ​= ​75) and poor prognosis (n ​= ​69) groups. The levels of alpha-fetoprotein (AFP), carbohydrate antigen (CA19-9), and carcinoembryonic antigen (CEA) before and after MWA were analysed using an independent sample t-test. The correlation between prognosis, ablation lesion area, and tumour marker levels were analysed by Pearson's correlation. The diagnostic power of the ablation lesion area combined with tumour marker levels for the prognosis of patients with MWA was analysed using receiver operating characteristic (ROC) curves.</p><p><strong>Results: </strong>The levels of AFP, CA19-9, and CEA in the good prognosis group were significantly lower than those in the poor prognosis group (all P ​< ​0.001). The levels of all tumour markers were significantly negatively correlated with the prognosis of patients who underwent MWA (all r ​< ​0, P ​< ​0.001) and positively correlated with the area of tumour-ablated lesions (r ​> ​0, P ​< ​0.001). Moreover, the diagnostic efficacy of CEUS combined with tumour markers for the prognosis of patients who underwent MWA was significantly higher than that of either single diagnostic modality.</p><p><strong>Conclusions: </strong>CEUS combined with tumour marker monitoring can effectively improve the accuracy of prognostic diagnosis in patients with MWA and provide a reference for timely and reasonable treatment and therapeutic evaluation.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":"79-85"},"PeriodicalIF":2.5,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142926237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To shock or not to shock - The accuracy of cardiac arrest rhythm assessment by paramedics in a simulated environment. 电击还是不电击——护理人员在模拟环境中心脏骤停节律评估的准确性。
IF 2.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-18 DOI: 10.1016/j.advms.2024.12.002
Jerzy Jaskuła, Katarzyna Stolarz-Skrzypek, Klaudia Jaskuła, Jerzy Wordliczek, Grzegorz Cebula, Wojciech Zaręba, Małgorzata Kloch

Purpose: Defibrillation in shockable rhythm is a well-known key intervention in cardiopulmonary resuscitation (CPR). The aim of this study was to analyze accuracy (the sum of the numbers of true positive results and true negative results, divided by the number of total results) of deciding by paramedics whether the rhythm was shockable or non-shockable.

Methods: In this study 103 paramedics from various regions of Poland participated voluntarily. Study participants were presented with 22 simulated various electrocardiogram (ECG) recordings based on 10-s videos. These rhythms were also assessed using a manual defibrillator with shock-advisory mode known as automated external defibrillator (AED) mode.

Results: Among the 103 participants, the mean of correct answers (correct decision to defibrillate or correct decision not to defibrillate) was 18/22 (83.7 ​%). The highest possible score was achieved by the participant with 22/22 (100 ​%) correct answers, while the lowest was 10/22 (45.5 ​%). The highest score obtained for single rhythm was 97.1 ​% and the lowest was 32 ​%. Mean accuracy of shock-advisory mode was 77.3 ​%.

Conclusions: Improving the quality of paramedic training and continuous quality monitoring (e.g., by analyzing ECG recordings from resuscitations) is essential to improve the accuracy of defibrillation rhythm recognition. The role of the AED mode can be advisory, but is not a substitute for assessment by medical professionals in Emergency Medical Service.

目的:休克心律除颤是众所周知的心肺复苏(CPR)的关键干预措施。本研究的目的是分析护理人员判断心律是震荡还是非震荡的准确性(真阳性结果和真阴性结果的总和,除以总结果的数量)。方法:在本研究中,来自波兰不同地区的103名护理人员自愿参与。研究参与者观看了22个基于10秒视频的模拟心电图(ECG)记录。这些节律也使用具有休克咨询模式的手动除颤器进行评估,称为自动体外除颤器(AED)模式。结果:在103名参与者中,正确答案(正确决定除颤器或正确决定不除颤器)的平均值为18/22(83.7%)。满分为22/22(100%),最低为10/22(45.5%)。单节律得分最高为97.1%,最低为32%。冲击预警模式的平均准确率为77.3%。结论:提高护理人员的培训质量和持续的质量监测(例如,通过分析复苏的心电图记录)对于提高除颤节律识别的准确性至关重要。AED模式的作用可以是咨询,但不能代替医疗专业人员在紧急医疗服务中的评估。
{"title":"To shock or not to shock - The accuracy of cardiac arrest rhythm assessment by paramedics in a simulated environment.","authors":"Jerzy Jaskuła, Katarzyna Stolarz-Skrzypek, Klaudia Jaskuła, Jerzy Wordliczek, Grzegorz Cebula, Wojciech Zaręba, Małgorzata Kloch","doi":"10.1016/j.advms.2024.12.002","DOIUrl":"10.1016/j.advms.2024.12.002","url":null,"abstract":"<p><strong>Purpose: </strong>Defibrillation in shockable rhythm is a well-known key intervention in cardiopulmonary resuscitation (CPR). The aim of this study was to analyze accuracy (the sum of the numbers of true positive results and true negative results, divided by the number of total results) of deciding by paramedics whether the rhythm was shockable or non-shockable.</p><p><strong>Methods: </strong>In this study 103 paramedics from various regions of Poland participated voluntarily. Study participants were presented with 22 simulated various electrocardiogram (ECG) recordings based on 10-s videos. These rhythms were also assessed using a manual defibrillator with shock-advisory mode known as automated external defibrillator (AED) mode.</p><p><strong>Results: </strong>Among the 103 participants, the mean of correct answers (correct decision to defibrillate or correct decision not to defibrillate) was 18/22 (83.7 ​%). The highest possible score was achieved by the participant with 22/22 (100 ​%) correct answers, while the lowest was 10/22 (45.5 ​%). The highest score obtained for single rhythm was 97.1 ​% and the lowest was 32 ​%. Mean accuracy of shock-advisory mode was 77.3 ​%.</p><p><strong>Conclusions: </strong>Improving the quality of paramedic training and continuous quality monitoring (e.g., by analyzing ECG recordings from resuscitations) is essential to improve the accuracy of defibrillation rhythm recognition. The role of the AED mode can be advisory, but is not a substitute for assessment by medical professionals in Emergency Medical Service.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":"51-56"},"PeriodicalIF":2.5,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142870971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic immune-inflammation index in the evaluation of Sjogren's syndrome associated with interstitial lung disease, interstitial pneumonia with autoimmune features, and idiopathic pulmonary fibrosis. 评估与间质性肺病相关的干燥综合征、具有自身免疫性特征的间质性肺炎和特发性肺纤维化的全身性免疫炎症指数
IF 2.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-12-14 DOI: 10.1016/j.advms.2024.12.001
Gokhan Sargin, Kursad Baris, Sule Tas Gulen

Purpose: Interstitial lung disease (ILD) damages the lungs and can be caused by environmental exposures and collagen-vascular diseases. The systemic immune-inflammation index (SII) is investigated to diagnose and manage ILDs in different etiological diseases. The study aims to examine the usefulness of SII in diagnosing specific ILDs like Sjogren's syndrome (SjS)-ILD, interstitial pneumonia with autoimmune features (IPAF), and idiopathic pulmonary fibrosis (IPF).

Materials and methods: In this cross-sectional study, we included 109 patients with IPAF, IPF, and SjS-ILD. Demographic characteristics, symptoms, lung patterns, autoantibodies, and SII were assessed. Morphologic, serologic, and clinical factors determined the classification of IPAF. Student's t-test, Mann-Whitney U test, Pearson-Spearman's method, and receiver operating characteristic (ROC) curves were used to analyze data.

Results: Male patients were more common in IPF and IPAF, while SjS-ILD had mostly female patients. Raynaud's phenomenon and dry mouth/eyes were more common in SjS-ILD compared to IPF and IPAF. The groups had significant differences in patterns, antinuclear antibody positivity, and SII levels. SII levels differed significantly between IPAF, SjS-ILD, and IPF patients, and were correlated with CRP in IPAF and SjS-ILD. The cut-off value of the SII between IPAF and IPF in patients with ILD was 576.1 with 76.0 ​% sensitivity and 76.0 ​% specificity.

Conclusions: Evaluation of SII provides valuable information for understanding and identifying different disease groups with ILDs.

目的:间质性肺病(ILD)损害肺部,可由环境暴露和胶原血管疾病引起。全身免疫炎症指数(SII)被用来诊断和治疗不同病因的间质性肺病。本研究旨在探讨 SII 在诊断特定 ILD(如 Sjogren's 综合征(SjS)-ILD、具有自身免疫特征的间质性肺炎(IPAF)和特发性肺纤维化(IPF))时的实用性:在这项横断面研究中,我们纳入了 109 名 IPAF、IPF 和 SjS-ILD 患者。对患者的人口统计学特征、症状、肺部形态、自身抗体和 SII 进行了评估。形态学、血清学和临床因素决定了 IPAF 的分类。数据分析采用了学生 t 检验、Mann-Whitney U 检验、Pearson-Spearman 方法和接收器操作特征曲线(ROC):结果:男性患者在 IPF 和 IPAF 中更为常见,而 SjS-ILD 则以女性患者居多。与 IPF 和 IPAF 相比,SjS-ILD 更常见雷诺现象和口干/眼干。各组在模式、抗核抗体阳性率和 SII 水平方面存在明显差异。SII水平在IPAF、SjS-ILD和IPF患者之间存在明显差异,在IPAF和SjS-ILD中与CRP相关。在 ILD 患者中,IPAF 和 IPF 之间的 SII 临界值为 576.1,灵敏度为 76.0%,特异度为 76.0%:结论:评估 SII 可为了解和识别 ILD 不同疾病组提供有价值的信息。
{"title":"Systemic immune-inflammation index in the evaluation of Sjogren's syndrome associated with interstitial lung disease, interstitial pneumonia with autoimmune features, and idiopathic pulmonary fibrosis.","authors":"Gokhan Sargin, Kursad Baris, Sule Tas Gulen","doi":"10.1016/j.advms.2024.12.001","DOIUrl":"10.1016/j.advms.2024.12.001","url":null,"abstract":"<p><strong>Purpose: </strong>Interstitial lung disease (ILD) damages the lungs and can be caused by environmental exposures and collagen-vascular diseases. The systemic immune-inflammation index (SII) is investigated to diagnose and manage ILDs in different etiological diseases. The study aims to examine the usefulness of SII in diagnosing specific ILDs like Sjogren's syndrome (SjS)-ILD, interstitial pneumonia with autoimmune features (IPAF), and idiopathic pulmonary fibrosis (IPF).</p><p><strong>Materials and methods: </strong>In this cross-sectional study, we included 109 patients with IPAF, IPF, and SjS-ILD. Demographic characteristics, symptoms, lung patterns, autoantibodies, and SII were assessed. Morphologic, serologic, and clinical factors determined the classification of IPAF. Student's t-test, Mann-Whitney U test, Pearson-Spearman's method, and receiver operating characteristic (ROC) curves were used to analyze data.</p><p><strong>Results: </strong>Male patients were more common in IPF and IPAF, while SjS-ILD had mostly female patients. Raynaud's phenomenon and dry mouth/eyes were more common in SjS-ILD compared to IPF and IPAF. The groups had significant differences in patterns, antinuclear antibody positivity, and SII levels. SII levels differed significantly between IPAF, SjS-ILD, and IPF patients, and were correlated with CRP in IPAF and SjS-ILD. The cut-off value of the SII between IPAF and IPF in patients with ILD was 576.1 with 76.0 ​% sensitivity and 76.0 ​% specificity.</p><p><strong>Conclusions: </strong>Evaluation of SII provides valuable information for understanding and identifying different disease groups with ILDs.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":"57-61"},"PeriodicalIF":2.5,"publicationDate":"2024-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142826833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Caloric restriction mimetics: Pinostilbene versus resveratrol regarding SIRT1 and SIRT6 interaction. 热量限制模拟:蒎烯与白藜芦醇对SIRT1和SIRT6相互作用的影响。
IF 2.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-29 DOI: 10.1016/j.advms.2024.11.002
Anca Ungurianu, Denisa Margină, Dragoș P Mihai, Alina C Nicolae, Cristina M Drăgoi, Daniela Grădinaru, Anca Zanfirescu

Purpose: Caloric restriction (CR), the permanent or periodic reduction of caloric intake, is a dietary strategy that promotes longevity and healthspan, yielding multiple beneficial effects, such as improved insulin sensitivity and mitochondrial function, decreased body weight, and mitigation of cardiometabolic risk factors. The purpose of our study was the in silico and in vitro assessment of the effects exerted by pinostilbene on SIRT1 and SIRT6 compared to those of resveratrol, a known activator of these enzymes.

Materials and methods: Molecular docking was carried out to determine the interactions with SIRT1 and SIRT6 and, further, the effect of pinostilbene on their activity was tested in vitro to evaluate if it parallels resveratrol's effects regarding SIRT activation.

Results: Molecular docking indicates that resveratrol and pinostilbene bind similarly to SIRT6, while pinostilbene may be able to activate SIRT1 more efficiently than resveratrol. In vitro activity assays showed that while both resveratrol and pinostilbene activate SIRT1 and SIRT6, the concentration-dependent effects differ. For resveratrol, a greater effect was observed at the medium concentration (25 ​μM), whereas pinostilbene showed a more pronounced activation at the lowest concentration (5 ​μM).

Conclusions: Our results offer a glimpse into the structural features and interactions of pinostilbene and resveratrol with SIRT1 and SIRT6, contributing to understanding their potential roles in various cellular processes regulated by SIRT.

目的:热量限制(CR),即永久或定期减少热量摄入,是一种促进长寿和健康的饮食策略,可产生多种有益效果,如改善胰岛素敏感性和线粒体功能,降低体重,减轻心脏代谢危险因素。我们研究的目的是在体内和体外评估pinostilbene对SIRT1和SIRT6的影响,并与白藜芦醇(一种已知的这些酶的激活剂)进行比较。材料与方法:通过分子对接确定与SIRT1和SIRT6的相互作用,并进一步在体外测试蒎烯对其活性的影响,以评估其是否与白藜芦醇对SIRT激活的作用相似。结果:分子对接表明,白藜芦醇和蒎烯与SIRT6的结合相似,而蒎烯可能比白藜芦醇更有效地激活SIRT1。体外活性分析表明,尽管白藜芦醇和蒎烯都能激活SIRT1和SIRT6,但其浓度依赖性不同。对于白藜芦醇,在中等浓度(25 μM)下的活化效果更明显,而蒎烯在最低浓度(5 μM)下的活化效果更明显。结论:我们的研究结果揭示了蒎烯二苯乙烯和白藜芦醇与SIRT1和SIRT6的结构特征和相互作用,有助于了解它们在SIRT调控的各种细胞过程中的潜在作用。
{"title":"Caloric restriction mimetics: Pinostilbene versus resveratrol regarding SIRT1 and SIRT6 interaction.","authors":"Anca Ungurianu, Denisa Margină, Dragoș P Mihai, Alina C Nicolae, Cristina M Drăgoi, Daniela Grădinaru, Anca Zanfirescu","doi":"10.1016/j.advms.2024.11.002","DOIUrl":"10.1016/j.advms.2024.11.002","url":null,"abstract":"<p><strong>Purpose: </strong>Caloric restriction (CR), the permanent or periodic reduction of caloric intake, is a dietary strategy that promotes longevity and healthspan, yielding multiple beneficial effects, such as improved insulin sensitivity and mitochondrial function, decreased body weight, and mitigation of cardiometabolic risk factors. The purpose of our study was the in silico and in vitro assessment of the effects exerted by pinostilbene on SIRT1 and SIRT6 compared to those of resveratrol, a known activator of these enzymes.</p><p><strong>Materials and methods: </strong>Molecular docking was carried out to determine the interactions with SIRT1 and SIRT6 and, further, the effect of pinostilbene on their activity was tested in vitro to evaluate if it parallels resveratrol's effects regarding SIRT activation.</p><p><strong>Results: </strong>Molecular docking indicates that resveratrol and pinostilbene bind similarly to SIRT6, while pinostilbene may be able to activate SIRT1 more efficiently than resveratrol. In vitro activity assays showed that while both resveratrol and pinostilbene activate SIRT1 and SIRT6, the concentration-dependent effects differ. For resveratrol, a greater effect was observed at the medium concentration (25 ​μM), whereas pinostilbene showed a more pronounced activation at the lowest concentration (5 ​μM).</p><p><strong>Conclusions: </strong>Our results offer a glimpse into the structural features and interactions of pinostilbene and resveratrol with SIRT1 and SIRT6, contributing to understanding their potential roles in various cellular processes regulated by SIRT.</p>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":" ","pages":"44-50"},"PeriodicalIF":2.5,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142765449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting treatment resistance in cervical cancer: A new avenue for senolytic therapies 针对宫颈癌的耐药性:老年溶解疗法的新途径
IF 2.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-11-15 DOI: 10.1016/j.advms.2024.11.001
Madré Meyer , Carla Fourie , Haynes van der Merwe , Hennie Botha , Anna-Mart Engelbrecht
Cervical cancer poses a significant global health challenge, particularly impacting women in economically developing nations. This disparity stems from a combination of factors, including inadequate screening infrastructure and resource limitations. However, the foremost contributor is the widespread lack of awareness and limited accessibility to Human Papillomavirus (HPV) vaccination, which is a key preventative measure against cervical cancer development. Despite advancements in cervical cancer prevention, treatment resistance remains a major hurdle in achieving improved patient outcomes. Cellular senescence, specifically the senescence-associated secretory phenotype (SASP) and its bidirectional relationship with the immune system, has been implicated in resistance to conventional cervical cancer chemotherapy treatments. The exact mechanisms by which this state of growth arrest and the associated changes in immune regulation contribute to cervical cancer progression and the associated drug resistance are not entirely understood. This underscores the necessity for innovative strategies to address the prevalence of treatment-resistant cervical cancer, with one promising avenue being the utilisation of senolytics. Senolytics are agents that have promising efficacy in clearing senescent cells from tumour tissues, however neither the utilisation of senolytics for addressing senescence-induced treatment resistance nor the potential integration of immunotherapy as senolytic agents in cervical cancer treatment has been explored to date. This review provides a concise overview of the mechanisms underlying senescence induction and the pivotal role of the immune system in this process. Additionally, it explores various senolytic approaches that hold significant potential for advancing cervical cancer research.
宫颈癌对全球健康构成了重大挑战,尤其影响到经济发展中国家的妇女。造成这种差异的因素很多,包括筛查基础设施不足和资源限制。然而,最主要的原因是人们普遍缺乏对人类乳头瘤病毒(HPV)疫苗接种的认识,而且接种机会有限,而接种HPV疫苗是预防宫颈癌发展的关键措施。尽管在宫颈癌预防方面取得了进展,但治疗耐药性仍是改善患者预后的一大障碍。细胞衰老,特别是衰老相关分泌表型(SASP)及其与免疫系统的双向关系,已被认为与传统宫颈癌化疗的耐药性有关。这种生长停滞状态和相关的免疫调节变化导致宫颈癌进展和相关耐药性的确切机制尚不完全清楚。这凸显了采用创新策略来解决宫颈癌耐药问题的必要性,其中一个很有前景的方法就是使用抗衰老剂。衰老剂是一种在清除肿瘤组织中衰老细胞方面具有良好疗效的药物,但迄今为止,还没有人探索过利用衰老剂来解决衰老引起的耐药性问题,也没有人探索过将免疫疗法作为衰老剂整合到宫颈癌治疗中的可能性。本综述简要概述了衰老诱导的基本机制以及免疫系统在这一过程中的关键作用。此外,它还探讨了在推进宫颈癌研究方面具有巨大潜力的各种衰老溶解方法。
{"title":"Targeting treatment resistance in cervical cancer: A new avenue for senolytic therapies","authors":"Madré Meyer ,&nbsp;Carla Fourie ,&nbsp;Haynes van der Merwe ,&nbsp;Hennie Botha ,&nbsp;Anna-Mart Engelbrecht","doi":"10.1016/j.advms.2024.11.001","DOIUrl":"10.1016/j.advms.2024.11.001","url":null,"abstract":"<div><div>Cervical cancer poses a significant global health challenge, particularly impacting women in economically developing nations. This disparity stems from a combination of factors, including inadequate screening infrastructure and resource limitations. However, the foremost contributor is the widespread lack of awareness and limited accessibility to Human Papillomavirus (HPV) vaccination, which is a key preventative measure against cervical cancer development. Despite advancements in cervical cancer prevention, treatment resistance remains a major hurdle in achieving improved patient outcomes. Cellular senescence, specifically the senescence-associated secretory phenotype (SASP) and its bidirectional relationship with the immune system, has been implicated in resistance to conventional cervical cancer chemotherapy treatments. The exact mechanisms by which this state of growth arrest and the associated changes in immune regulation contribute to cervical cancer progression and the associated drug resistance are not entirely understood. This underscores the necessity for innovative strategies to address the prevalence of treatment-resistant cervical cancer, with one promising avenue being the utilisation of senolytics. Senolytics are agents that have promising efficacy in clearing senescent cells from tumour tissues, however neither the utilisation of senolytics for addressing senescence-induced treatment resistance nor the potential integration of immunotherapy as senolytic agents in cervical cancer treatment has been explored to date. This review provides a concise overview of the mechanisms underlying senescence induction and the pivotal role of the immune system in this process. Additionally, it explores various senolytic approaches that hold significant potential for advancing cervical cancer research.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"70 1","pages":"Pages 33-43"},"PeriodicalIF":2.5,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142643687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Advances in medical sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1